AKT1 and cancer: Potential drug-like compounds that can inhibit cancer cell progression by negatively inhibiting Akt phosphorylation and downregulation of Akt kinase, thus regulating the PI3K-Akt pathway, could be a potential anticancer drug (Tao et al., 2017; Mart et al., 2023).